Wall Street Journal20d
ICE Arrest of Columbia Student Marks New Era of Campus Politics
Mahmoud Khalil, a Columbia University student who helped lead last year’s pro-Palestinian demonstrations, was detained by the Department of Homeland Security on Saturday. Photo: Jeenah Moon ...
Business Line21d
Syngene acquires first US facility from Emergent Manufacturing
Syngene International, the contract research wing of Biocon Group, has acquired its first manufacturing facility in the US from Emergent Manufacturing Operations Baltimore. The pharma player has ...
cnbctv1823d
Biocon Biologics’ biosimilar Yesintek shows positive phase 3 results for psoriasis treatment
Biotechnology firm Biocon Ltd on Friday (March 7) said its subsidiary Biocon Biologics Ltd has announced positive results from its phase 3 clinical trial for Yesintek, a biosimilar to ustekinumab ...
Daily23d
Biocon Biologics, Civica join hands to expand Insulin Aspart access in US
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, and Civica, Inc., a not-for-profit generic drug and pharmaceutical company, have announced ...
Indiatimes23d
Biocon shares climb 1% on partnership with Civica to boost insulin aspart availability in the US
Biocon Biologics has partnered with Civica to improve access to and affordability of insulin aspart in the U.S. Biocon will supply the insulin, while Civica will manufacture and commercialize it, ...
Yahoo Finance24d
Biocon Biologics Announces Positive Results from Phase 3 Study of Yesintek™ Biosimilar to Ustekinumab for Chronic Plaque Psoriasis
BRIDGEWATER, N.J., and BENGALURU, India, March 7, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code ...
moneycontrol.com24d
Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March
The company's subsidiary, Biocon Biologics, announced a strategic collaboration agreement with Civica, Inc. to expand access and affordability of Insulin Aspart in the United States. As per the ...
Business Standard24d
Biocon Biologics collaborates with Civica
To supply Aspart drug substance and expand patient access to Insulin Aspart in the US Biocon Biologics and Civica, Inc. (Civica), a not-for-profit generic drug and pharmaceutical company founded in ...
BioSpace24d
Biocon Biologics and Civica, Inc. Collaborate to Expand Insulin Aspart Access in the United States
BRIDGEWATER, N.J. and PETERSBURG, Va. and BENGALURU, India, March 6, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company ...
The Financial Express24d
Biocon Biologics partners with Civica to expand Insulin Aspart access in United States
Biocon Biologics and Civica, Inc. on Thursday announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States. According to the company’s ...
Stocks to Watch Today: TCS, Quess Corp, Power Grid Corporation, Eris Lifesciences, Omaxe, Kalpataru Projects, Biocon in focus on 7 March
Stocks like Tamilnad Mercantile Bank, NMDC, Jindal Stainless, Sudarshan Pharma Industries, Brigade Enterprises, Rail Vikas Nigam, RITES, Laurus Labs, Bharat Electronics, InterGlobe Aviation, ...
money.rediff24d
Biocon Biologics Expands Diabetes Drug Access in US
Biocon Biologics partners with Civica Inc to increase affordability and access to Insulin Aspart in the US, targeting the 38.4 million Americans with diabetes. New Delhi, Mar 6 (PTI) Biocon Biologics ...